AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26500170 — intervention group
Group type: EXPERIMENTAL
Intervention: CSM referral letter + DIG
Number of subjects: 0
Study 26500170 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced CSM referral letter alone
Number of subjects: 0
Study 26500170 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced CSM referral letter + DIG
Number of subjects: 0
Study 26500170 — intervention group
Group type: COMPARATOR
Intervention: Standard (control) referral
Number of subjects: 0
Study 24285599 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g fish oil/day (540 mg eicosapentaenoic acid + 360 mg docosahexaenoic acid)
Number of subjects: 83
Study 24285599 — intervention group
Group type: COMPARATOR
Intervention: 3 g soy oil/day (placebo)
Number of subjects: 83
Study 22990031 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate supplementation (1000 mg Ca/d, 5 d/wk) for 12 months
Number of subjects: 160
Study 20149038 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute oral hydration
Number of subjects: 44
Study 20149038 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 44
Study 17316154 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa administered weekly, every 2 weeks, and every 3 weeks
Number of subjects: 0
Study 17316154 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (weight-based and fixed dosing)
Number of subjects: 0
Study 17316154 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa at extended dosing intervals of at least 3 weeks
Number of subjects: 0
Study 17316154 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 0
Study 15182768 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler indices of transmitral flow measurements
Number of subjects: 355
Study 11579362 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 768
Study 11579362 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 768
Study 11579362 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan and Enalapril combination
Number of subjects: 768
Study 11579362 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril alone
Number of subjects: 768
Study 11579362 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 768
Study 11579362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 768
Study 9833602 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 10 min
Number of subjects: 8
Study 9833602 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 30 min
Number of subjects: 8
Study 9833602 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 100 min
Number of subjects: 8
Study 9833602 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 300 min
Number of subjects: 8
Study 10471100 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 + zidovudine
Number of subjects: 40
Study 10471100 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 + placebo
Number of subjects: 40
Study 10471100 — intervention group
Group type: COMPARATOR
Intervention: zidovudine
Number of subjects: 40
Study 10471100 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160
Number of subjects: 40
Study 2051246 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand articulation of the casts prior to mounting the lower cast against the upper cast
Number of subjects: 53
Study 2051246 — intervention group
Group type: COMPARATOR
Intervention: Low‐viscosity polyether interdental registration material
Number of subjects: 53
Study 6188739 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B
Number of subjects: 230
Study 6188739 — intervention group
Group type: COMPARATOR
Intervention: Neomycin-polymyxin B-gramicidin
Number of subjects: 230
Study 6188739 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 230
Study 28445230 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Plyometric Training (U)
Number of subjects: 15
Study 28445230 — intervention group
Group type: COMPARATOR
Intervention: Bilateral Plyometric Training (B)
Number of subjects: 15
Study 30231173 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% HA gel
Number of subjects: 16
Study 30231173 — intervention group
Group type: COMPARATOR
Intervention: Control (blood clot)
Number of subjects: 16
Study 30231173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 26511668 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy and surgery (nCRTS)
Number of subjects: 170
Study 26511668 — intervention group
Group type: COMPARATOR
Intervention: surgery alone
Number of subjects: 170
Study 26511668 — intervention group
Group type: EXPERIMENTAL
Intervention: adenocarcinoma
Number of subjects: 170
Study 26511668 — intervention group
Group type: EXPERIMENTAL
Intervention: squamous cell cancer
Number of subjects: 170
Study 26511668 — intervention group
Group type: EXPERIMENTAL
Intervention: ypT0N0 category
Number of subjects: 170
Study 26511668 — intervention group
Group type: EXPERIMENTAL
Intervention: node-positive disease
Number of subjects: 170
Study 24583615 — intervention group
Group type: EXPERIMENTAL
Intervention: Shang Ring
Number of subjects: 400
Study 24583615 — intervention group
Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 400
Study 24583615 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 400
Study 23212497 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week rotations
Number of subjects: 62
Study 23212497 — intervention group
Group type: COMPARATOR
Intervention: 4-week rotations
Number of subjects: 62
Study 20693270 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH351125 (oral CCR5 inhibitor)
Number of subjects: 32
Study 20693270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 19049265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% moxifloxacin (MFLX)
Number of subjects: 0
Study 19049265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% gatifloxacin (GFLX)
Number of subjects: 0
Study 19049265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levofloxacin (LVFX)
Number of subjects: 0
Study 16466171 — intervention group
Group type: EXPERIMENTAL
Intervention: Daidzein Tablets for 6 weeks
Number of subjects: 40
Study 16466171 — intervention group
Group type: COMPARATOR
Intervention: Conventional medicine
Number of subjects: 40
Study 12825038 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid nasal dressing (MeroGel)
Number of subjects: 37
Study 12825038 — intervention group
Group type: COMPARATOR
Intervention: Nonabsorbable packing (Merocel)
Number of subjects: 37
Study 10648312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate suppositories
Number of subjects: 301
Study 10648312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 9081681 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 23
Study 9081681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 8382708 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg tirilazad mesylate
Number of subjects: 47
Study 8382708 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg tirilazad mesylate
Number of subjects: 47
Study 8382708 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg tirilazad mesylate
Number of subjects: 47
Study 8382708 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg tirilazad mesylate
Number of subjects: 47
Study 8382708 — intervention group
Group type: COMPARATOR
Intervention: Citrate vehicle
Number of subjects: 47
Study 2876337 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial food additives
Number of subjects: 43
Study 2876337 — intervention group
Group type: COMPARATOR
Intervention: Normal diet re-introduced after additive-free diet
Number of subjects: 43
Study 2876337 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin sensitivity
Number of subjects: 43
Study 2876337 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopy prevalence
Number of subjects: 43
Study 30900668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching + 10% sodium ascorbate (antioxidant)
Number of subjects: 50
Study 30900668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching + green tea
Number of subjects: 50
Study 30900668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching + white tea
Number of subjects: 50
Study 30900668 — intervention group
Group type: COMPARATOR
Intervention: Bleaching only
Number of subjects: 50
Study 30900668 — intervention group
Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 50
Study 30594335 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy including neurodynamic techniques (MT), conducted twice weekly for 20 therapy sessions.
Number of subjects: 189
Study 30594335 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; without therapy).
Number of subjects: 189
Study 30594335 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy including neurodynamic techniques (MT).
Number of subjects: 189
Study 26292798 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice a day for 3 months
Number of subjects: 107
Study 26292798 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with Omeprazole)
Number of subjects: 107
Study 26292798 — intervention group
Group type: EXPERIMENTAL
Intervention: RSI-CH
Number of subjects: 107
Study 23890962 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic thyroidectomy using the oral vestibular approach (ETOVA)
Number of subjects: 24
Study 23890962 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic thyroidectomy by areola approach (ETAA)
Number of subjects: 24
Study 23084677 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate carboxymethylcellulose hyaluronic acid (ACH)
Number of subjects: 187
Study 23084677 — intervention group
Group type: COMPARATOR
Intervention: Carboxymethylcellulose hyaluronic acid (CH)
Number of subjects: 187
Study 21290830 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 97
Study 21290830 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric stimulation (group B)
Number of subjects: 97
Study 21290830 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (group C)
Number of subjects: 97
Study 17984504 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical viscodissection (Group 1)
Number of subjects: 23
Study 17984504 — intervention group
Group type: COMPARATOR
Intervention: Non‐viscodissection (Group 2)
Number of subjects: 23
Study 15860969 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 123
Study 15860969 — intervention group
Group type: COMPARATOR
Intervention: IV nitroglycerin
Number of subjects: 123
Study 12492610 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (8 mg once a day)
Number of subjects: 11
Study 12492610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 7899525 — intervention group
Group type: EXPERIMENTAL
Intervention: Work rehabilitation program participation
Number of subjects: 0
Study 7899525 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills and personal presentation
Number of subjects: 0
Study 7899525 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive disorganization and intelligence quotient
Number of subjects: 0
Study 7899525 — intervention group
Group type: COMPARATOR
Intervention: Psychopathology levels
Number of subjects: 0
Study 3028456 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril maleate 10 mg
Number of subjects: 0
Study 3028456 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide 80 mg
Number of subjects: 0
Study 3028456 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant use of enalapril and frusemide
Number of subjects: 0
Study 29768938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger extract (400 mg, 5% active ingredient)
Number of subjects: 60
Study 29768938 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 60
Study 28603411 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 240
Study 28603411 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 240
Study 26410011 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin re‐uptake inhibitor (SSRI)
Number of subjects: 1000
Study 26410011 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 1000
Study 22822928 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of flurbiprofen (40 mg administered twice at 16 and 2 hours before surgery)
Number of subjects: 16
Study 22822928 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of flurbiprofen (40 mg administered twice at 16 and 2 hours before surgery)
Number of subjects: 16
Study 21534680 — intervention group
Group type: EXPERIMENTAL
Intervention: Social‐cognitive‐emotional (SCE) intervention
Number of subjects: 176
Study 21534680 — intervention group
Group type: COMPARATOR
Intervention: Social‐cognitive (SC) intervention
Number of subjects: 176
Study 19793621 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor cortex stimulation (MCS)
Number of subjects: 5
Study 16477496 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide (6 pmol/kg/min)
Number of subjects: 8
Study 16477496 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 8
Study 15117238 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% GTN gel twice a day for a minimum of 6 weeks
Number of subjects: 80
Study 11284826 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of ondansetron
Number of subjects: 80
Study 11284826 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 80
Study 9266226 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (HCG)
Number of subjects: 0
Study 9266226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate dehydrogenase (LDH)
Number of subjects: 0
Study 9266226 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental alkaline phosphatase (PlAP)
Number of subjects: 0
Study 9266226 — intervention group
Group type: EXPERIMENTAL
Intervention: At least one of the three markers (HCG, LDH, PlAP)
Number of subjects: 0
Study 7906128 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one educational presentation by a clinical pharmacist, written educational materials, brief follow-up visit, and feedback with recommendations (Group 1)
Number of subjects: 91
Study 7906128 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face presentation to departmental groups and the same written educational materials (Group 2)
Number of subjects: 91
Study 7906128 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 91
Study 3285630 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of etretinate and PUVA
Number of subjects: 94
Study 3285630 — intervention group
Group type: COMPARATOR
Intervention: Etretinate
Number of subjects: 94
Study 3285630 — intervention group
Group type: COMPARATOR
Intervention: PUVA
Number of subjects: 94
Study 3285630 — intervention group
Group type: COMPARATOR
Intervention: UVB
Number of subjects: 94
Study 3285630 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study 29607842 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin gel
Number of subjects: 20
Study 29607842 — intervention group
Group type: COMPARATOR
Intervention: Platelet-rich fibrin membrane
Number of subjects: 20
Study 27749775 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted lemon juice before stress imaging and diluted lemon juice with soda water before rest imaging (Group A)
Number of subjects: 230
Study 27749775 — intervention group
Group type: COMPARATOR
Intervention: Soda water before stress imaging and diluted lemon juice before rest imaging (Group B)
Number of subjects: 230
Study 27749775 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (Group A)
Number of subjects: 230
Study 25599738 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC plus routine immunosuppressive regimen (n = 33)
Number of subjects: 84
Study 25599738 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC and vitamin C plus routine regimen (n = 19)
Number of subjects: 84
Study 25599738 — intervention group
Group type: COMPARATOR
Intervention: Routine anti-rejection medication only (n = 32)
Number of subjects: 84
Study 23295965 — intervention group
Group type: EXPERIMENTAL
Intervention: MEP targeted injections in the psoas muscle
Number of subjects: 7
Study 23295965 — intervention group
Group type: COMPARATOR
Intervention: Distal injections in the psoas muscle
Number of subjects: 7
Study 21075366 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted thermal dose based on ovarian volume (60 J/cm³ of ovarian tissue)
Number of subjects: 120
Study 21075366 — intervention group
Group type: COMPARATOR
Intervention: Fixed thermal dosage (600 J per ovary)
Number of subjects: 120
Study 19225955 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) for catatonic schizophrenia
Number of subjects: 53
Study 19225955 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT) for non-catatonic schizophrenia
Number of subjects: 53
Study 17369574 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib interrupted (INT)
Number of subjects: 182
Study 17369574 — intervention group
Group type: COMPARATOR
Intervention: Imatinib continuous (CONT)
Number of subjects: 182
Study 17369574 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (both INT and CONT)
Number of subjects: 182
Study 15533104 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral wedge
Number of subjects: 236
Study 15533104 — intervention group
Group type: COMPARATOR
Intervention: Control (no sacral wedge)
Number of subjects: 236
Study 12018562 — intervention group
Group type: EXPERIMENTAL
Intervention: Long acting nifedipine (nicardia retard 20)
Number of subjects: 30
Study 12018562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no long acting nifedipine)
Number of subjects: 30
Study 9041511 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity laser irradiation (830nm; 1.5J/cm2)
Number of subjects: 48
Study 9041511 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity laser irradiation (830nm; 9.0J/cm2)
Number of subjects: 48
Study 9041511 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham irradiation)
Number of subjects: 48
Study 7701222 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 143
Study 7701222 — intervention group
Group type: COMPARATOR
Intervention: Caldwell-Luc (C-L) procedure
Number of subjects: 143
Study 3606702 — intervention group
Group type: EXPERIMENTAL
Intervention: benzoxonium chloride tablets and gelsolets at doses of 6 mg and 10 mg daily for 4 to 6 days
Number of subjects: 38
Study 3606702 — intervention group
Group type: COMPARATOR
Intervention: gargle solutions
Number of subjects: 38
Study 29275119 — intervention group
Group type: EXPERIMENTAL
Intervention: Momelotinib 200 mg once a day for 24 weeks
Number of subjects: 156
Study 29275119 — intervention group
Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 156
Study 29275119 — intervention group
Group type: EXPERIMENTAL
Intervention: Momelotinib
Number of subjects: 156
Study 29275119 — intervention group
Group type: COMPARATOR
Intervention: BAT
Number of subjects: 156
Study 27473256 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded mini-implants after implant placement
Number of subjects: 80
Study 27473256 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading of mini-implants after four months (control group)
Number of subjects: 80
Study 26435245 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate passive mobilization
Number of subjects: 130
Study 26435245 — intervention group
Group type: COMPARATOR
Intervention: Delayed mobilization (immobilization for 4 weeks)
Number of subjects: 130
Study 26435245 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography at 6 weeks
Number of subjects: 130
Study 24084309 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based practice
Number of subjects: 48
Study 24084309 — intervention group
Group type: COMPARATOR
Intervention: Classroom-based practice
Number of subjects: 48
Study 21339196 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Number of subjects: 233
Study 21339196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study 18381485 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of an automated external defibrillator (AED) followed by calling emergency medical services and performing CPR
Number of subjects: 7001
Study 18381485 — intervention group
Group type: COMPARATOR
Intervention: Control response (calling emergency medical services and performing CPR)
Number of subjects: 7001
Study 18381485 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of AED
Number of subjects: 7001
Study 16813849 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy of reduced pain (placebo)
Number of subjects: 84
Study 16813849 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain information
Number of subjects: 84
Study 16813849 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo analgesia
Number of subjects: 84
Study 16813849 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress measures (subjective stress, cortisol, circulating beta-endorphin)
Number of subjects: 84
Study 14652283 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum enterolactone concentration (measured in nmol/liter)
Number of subjects: 428
Study 14652283 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing quartiles of enterolactone concentration
Number of subjects: 428
Study 10694112 — intervention group
Group type: EXPERIMENTAL
Intervention: Field based exercise challenge (FBC)
Number of subjects: 23
Study 10694112 — intervention group
Group type: COMPARATOR
Intervention: Laboratory based exercise challenge (LBC)
Number of subjects: 23
Study 8792689 — intervention group
Group type: EXPERIMENTAL
Intervention: Caldwell needle/cannula (CNC)
Number of subjects: 40